Danaparoid Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06754 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 33 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Glanzmann thrombasthenia | KG + DL |
| 2 | primary release disorder of platelets | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 5 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 6 | Scott syndrome | KG + DL |
| 7 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 8 | platelet-type bleeding disorder | KG + DL |
| 9 | thrombotic thrombocytopenic purpura | KG + DL |
| 10 | flood factor deficiency | KG + DL |
| 11 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 12 | familial thrombomodulin anomalies | KG + DL |
| 13 | hemophilia | KG + DL |
| 14 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 15 | inherited thrombophilia | KG + DL |
| 16 | acquired coagulation factor deficiency | KG + DL |
| 17 | autosomal dominant macrothrombocytopenia | KG + DL |
| 18 | purpura fulminans | KG + DL |
| 19 | congenital factor V deficiency | KG + DL |
| 20 | methylcobalamin deficiency type cblG | KG + DL |
| 21 | autoimmune thrombocytopenic | KG + DL |
| 22 | Ledderhose disease | KG + DL |
| 23 | atypical hemolytic-uremic syndrome with thrombomodulin anomaly | KG + DL |
| 24 | neuropathy, painful | KG + DL |
| 25 | penile fibromatosis | KG + DL |
| 26 | pulmonary embolism (disease) | KG + DL |
| 27 | infantile digital fibromatosis | KG + DL |
| 28 | thrombocytopenic purpura | KG + DL |
| 29 | filariasis | KG + DL |
| 30 | palmar fibromatosis | KG + DL |
| 31 | thrombophilia due to protein C deficiency, autosomal recessive | KG + DL |
| 32 | Evans syndrome | KG + DL |
| 33 | acquired purpura fulminans | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.